The Clinical Research Department at Pen Bay Medical Center is currently enrolling patients in four clinical research studies.
The department consists of two staff, Caroline Knight, RN, CCRP, Clinical Research Specialist, and Tara Murray, RN, clinical research coordinator. The department's medical director is Dr. Robert Stein, neurologist.
The Clinical Research Department oversees medication and device trials at Pen Bay Medical Center. Through clinical research, physician-investigators translate laboratory discoveries into better treatments, therapies and interventions to improve the nation's health.
Please call (207)596-8959 for more information. Patients do not need a referral but should always feel free to ask their physician whether participation in a clinical study is appropriate for them.
AMPLIFY STUDY: This study is for patients who have just been diagnosed with either a deep vein thrombosis (DVT) in their leg or with a pulmonary embolus (PE). Participants receive either standard care or an investigational anti coagulant medication.
GOUT/CARDIOVASCULAR STUDY: This study is comparing two approved treatments for gout. The purpose is to determine if either drug is better or worse for patients with high risk of heart attack or stroke. Patients receive study medication for about three years.
DIABETES/CORONARY ARTERY DISEASE: This study is monitoring patients who have diabetes and have recently had a heart attack or revascularization. They receive any therapy their physicians prescribe and, in addition take either the investigational diabetes medication or placebo (inactive pill). The purpose is to determine if the investigational medication has any effect on the rate of cardiovascular events. Patients will receive medication for about four years.
BRIDGE STUDY: This research study aims to determine the effectiveness and safety of giving a medication as bridging anticoagulation to people with atrial fibrillation or atrial flutter who require temporary interruption of warfarin because of surgery or another procedure.